Status:
COMPLETED
Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)
Lead Sponsor:
University Hospital Center of Martinique
Conditions:
Left Ventricular Hypertrophy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The frequency of cardiac amyloidosis among patients presenting with a so-called left ventricular hypertrophy remains unknown. This problem is especially relevant in the Caribbean's, where an amyloidos...
Detailed Description
Cardiac amyloidosis is a very poorly known disease, in its frequency, its mechanisms, its treatment. This lack of knowledge is a major limitation to the improvement, indispensable, of the care of the ...
Eligibility Criteria
Inclusion
- Age \> 18 years,
- Residency in French Caribbean Regions
- Access to healthcare coverage,
- Written informed consent obtained
Exclusion
- Evidence of another cause for left ventricular hypertrophy (uncontrolled severe high blood pressure, untreated severe aortic stenosis, family history of hypertrophic cardiomyopathy)
- Inability to deliver informed consent,
- Presence of a known severe disease impending participation in the study
Key Trial Info
Start Date :
September 23 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2016
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT03322319
Start Date
September 23 2013
End Date
January 18 2016
Last Update
October 27 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Basse-Terre
Basse-Terre, Guadeloupe, 97100
2
CHU de Martinique
La Trinité, Martinique, 97220